Therapix Biosciences Ltd Nasdaqtrpxis A Specialty Clinical Stage Pharmaceutical Company Led By An Experienced Team Of Senior Executives And Scientistsour Focus Is Creating And Enhancing A Portfolio Of Technologies And Assets Based On Cannabinoid Pharmaceuticals With This Focusthe Company Is Currently Engaged In The Following Drug Development Programs Based On Repurposing An Fda Approved Cannabinoiddronabinol Thx 110 For The Treatment Of Tourette Syndromets For The Treatment Of Obstructive Sleep Apneaosa And The Treatment Of Painthx 130 For The Treatment Of Mild Cognitive Impairmentmciand Traumatic Brain Injurytbi Thx 150 For The Treatment Of Infectious Diseasesand Thx 160 For The Treatment Of Pain
No conferences found for this company.
| Company Name | Therapix Biosciences Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
